MCRA Appoints Director, Reimbursement Strategy Execution

MCRA has expanded its Reimbursement, Health Economics and Market Access Division through the hiring of Tess Wong, MS.

Ms. Wong will serve as Director, Reimbursement Strategy Execution, to expand MCRA’s medical technology market access expertise for commercial and government payors. Prior to joining MCRA, she worked at Medtronic where she implemented and executed health economics strategies that delivered economic value propositions for the company’s products and therapies. Her professional experience includes startup medical device companies as well as global orthopedic and spine medical device companies (Zimmer Biomet and SI-BONE).

Throughout her career, Ms. Wong has evaluated and interpreted U.S. and global healthcare systems, federal rules, reimbursement policies, technology assessments and economic analyses through retrospective data analysis and economic modeling. Furthermore, she has experience developing and implementing market reimbursement strategies for product launches, modeling economic burden and gaining majority consent of key opinion leaders for positive coverage policies.

At MCRA, Tess will establish systematic reimbursement, health economics, and market access strategies for client technologies throughout the total product lifecycle, to ensure a competitive advantage and market access in a value-based healthcare market.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE